Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery

Abstract

The aims of this study were to assess breast MRI and scintimammography (SMM) for the detection of breast cancer, and to determine any complementary role of these tests to each other and conventional imaging. Seventy-two patients (age 35-81 years) with a suspicious breast mass were investigated by mammography, breast ultrasound, breast MRI and SMM before undergoing surgical excision of the breast mass. Sensitivity, specificity and area under receiver operator characteristic curves were calculated for each test. Of the 72 patients, there were 66 proven malignant tumours, including two patients with bilateral breast cancer. When comparing the diagnostic sensitivity of breast MRI and SMM for lesion size, both tests showed higher sensitivities for lesions >25 mm in size, particularly for SMM. When these tests were compared for patient age, patients less than 51 years showed higher sensitivities for both tests. This was statistically significant for breast MRI. The overall respective diagnostic sensitivities for mammography, mammography with breast ultrasound, breast MRI and SMM were 56, 67, 86 and 85%. The differences were significant between mammography, mammography/ultrasound and both breast MRI and SMM. Breast MRI and SMM offer incremental diagnostic advantage in the diagnosis of breast cancer. Although improved diagnostic accuracy is seen in patients of all ages, those patients less than 51 years of age receive the greatest diagnostic benefit.

Cirurgia radioguiada com 99mTc-sestamibi intravenoso e ressonancia nuclear magnetica no cancer de mama

“…A literatura médica apresenta vários trabalhos utilizando RNM e CM no estudo do câncer de mama, porém sempre comparando a acurácia dos exames no diagnóstico da doença (Palmedo et al, 1996;Tiling et al, 1997;Imbriaco et al, 2001;Bagni et al, 2003;Bone et al, 2003;Howarth et al, 2005). Entretanto, não se encontram estudos associando os dois métodos para auxiliar no diagnóstico nem no tratamento do câncer de mama.…”